Dr. Hee-Young Park is a Professor and Chair of Medical Sciences & Education department at BUSM. She additional holds an administrative role as the Associate Dean of Faculty Affairs and oversees the faculty appointments and promotions at BUSM, as well as many other faculty related activities. Dr. Park received both B.S. and Ph.D. degrees from MIT and spent first 2 decades of her professional career as a biomedical researcher. Dr. Park’s research was focused on signaling pathways and factors that control skin color, aging and cutaneous wound healing. Specifically, she has made seminal contribution in these fields by discovering and characterizing the key role of serine/threonine kinases that turn on and off key enzymes and transcription factors. In addition to her research activities, she has consulted cosmetic and pharmaceutical companies interested in developing treatments for pigmentation-disorders and holds a patent for a method to decrease skin pigmentation. Dr. Park also has a long-standing interest in teaching and mentoring students. She has served as a faculty advisor and mentor to graduate students, medical students, residents and post-doctoral fellows.
- Professor, Dermatology (excluding Mohs Surgery), Dermatology, Boston University Chobanian & Avedisian School of Medicine
- Associate Dean for Faculty Affairs, Dean’s Office, Boston University Chobanian & Avedisian School of Medicine
- Chair, Medical Sciences & Education, Boston University Chobanian & Avedisian School of Medicine
- Graduate Faculty (Primary Mentor of Grad Students), Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
- Massachusetts Institute of Technology, PhD
- Massachusetts Institute of Technology, BS
- Published on 4/3/2018
Park HY, Berkowitz O, Symes K, Dasgupta S. The art and science of selecting graduate students in the biomedical sciences: Performance in doctoral study of the foundational sciences. PLoS One. 2018; 13(4):e0193901. PMID: 29614110.
- Published on 12/1/2014
Mitchell B, Leone D, Feller JK, Bondzie P, Yang S, Park HY, Mahalingam M. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status. Melanoma Res. 2014 Dec; 24(6):621-5. PMID: 25211166.
- Published on 10/1/2014
Belisle ES, Park HY. Metformin: a potential drug to treat hyperpigmentation disorders. J Invest Dermatol. 2014 Oct; 134(10):2488-91. PMID: 25219649.
- Published on 7/2/2014
Mitchell B, Leone D, Feller K, Menon S, Bondzie P, Yang S, Park HY, Mahalingam M. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility? Hum Pathol. 2014 Oct; 45(10):2094-100. PMID: 25130395.
- Published on 12/1/2012
Bae-Harboe YS, Park HY. Tyrosinase: a central regulatory protein for cutaneous pigmentation. J Invest Dermatol. 2012 Dec; 132(12):2678-80. PMID: 23187110.
- Published on 12/8/2011
Yaar M, Park HY. Melanocytes: a window into the nervous system. J Invest Dermatol. 2012 Mar; 132(3 Pt 2):835-45. PMID: 22158549.
- Published on 11/2/2010
Park HY, Kim JH, Ji JH, Ahn SK, Hong SP. Variant of phacomatosis pigmentokeratotica. J Dermatol. 2011 Jul; 38(7):719-22. PMID: 21352309.
- Published on 6/1/2010
Byers HR, Boissel SJ, Tu C, Park HY. RNAi-mediated knockdown of protein kinase C-alpha inhibits cell migration in MM-RU human metastatic melanoma cell line. Melanoma Res. 2010 Jun; 20(3):171-8. PMID: 20216103.
- Published on 12/30/2009
Park HY, Wu C, Yaar M, Stachur CM, Kosmadaki M, Gilchrest BA. Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes. Int J Cell Biol. 2009; 2009:750482. PMID: 20130821.
- Published on 5/1/2009
Park HY, Kosmadaki M, Yaar M, Gilchrest BA. Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci. 2009 May; 66(9):1493-506. PMID: 19153661.
View 15 more publications: View full profile at BUMC